{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/10/3341823/0/en/neonc-technologies-to-host-investor-conference-call-to-discuss-topline-phase-2a-results-for-intranasal-neo100-in-recurrent-idh1-mutant-high-grade-glioma.html", "message": "News view counter 872118 successfully enlarged"}